Marginal effect of obesity-related diseases on mortality rate for each age group.

<p>Marginal effect of obesity-related diseases on mortality rate for each age group.</p

Predicted life years lost associated with obesity-related diseases for U.S. non-smoking adults, 1997–2000^a.

<p>Notes: a. Bootstrapping means and standard errors in parentheses are presented; –: no observations in the sample.</p

Hazard ratios for death for each BMI classification (reference: the normal-weight).

<p>Hazard ratios for death for each BMI classification (reference: the normal-weight).</p

Descriptive statistics for U.S. non-smoking adults in the sample and the population, 1997–2000.

<p>Source: Authors’ calculations based on data from National Health Interview Survey, 1997–2000.</p><p>Notes: a. n: sample size; b. estimated population size; c. high school graduates; d. ORD: obesity-related diseases; e. the individual had had no more than 12 drinks of any type of alcoholic beverage in the individual’s entire life; f. the individual engaged in physical activities for 10 minutes at least once per week.</p

Flow chart outlining selection criteria of articles for content analysis.

<p>Flow chart outlining selection criteria of articles for content analysis.</p

Statistical measures and methods in <i>JAMA</i> articles published in 1990, 2000, and 2010^*.

<p>Statistical measures and methods in <i>JAMA</i> articles published in 1990, 2000, and 2010^{<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0077301#nt103" target="_blank">*</a>}.</p

Primary focus of 361 articles published in <i>JAMA</i> 1990, 2000, 2010.

<p>Primary focus of 361 articles published in <i>JAMA</i> 1990, 2000, 2010.</p

Characteristics of 361 articles published in <i>JAMA</i>, 1990, 2000, 2010.

<p>Characteristics of 361 articles published in <i>JAMA</i>, 1990, 2000, 2010.</p

Final model for the prediction of stillbirth at or beyond 32 weeks gestation excluding fetal anomalies and aneuploidy^a.

<p>Final model for the prediction of stillbirth at or beyond 32 weeks gestation excluding fetal anomalies and aneuploidy<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0173461#t003fn001" target="_blank">^a</a>.</p

Clinical performance of the stillbirth risk score to predict stillbirth at or beyond 32 weeks excluding fetal anomalies and aneuploidy.

<p>Clinical performance of the stillbirth risk score to predict stillbirth at or beyond 32 weeks excluding fetal anomalies and aneuploidy.</p